CRON - Cronos Group Inc.

1.85
0.020   1.081%

Share volume: 1,574,884
Last Updated: 04-29-2025
Pharmaceutical Products/Medicinal Chemicals: -0.08%

PREVIOUS CLOSE
CHG
CHG%
$1.83
0.02
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
49%
Profitability 22%
Dept financing 38%
Liquidity 0%
Performance 90%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
2.78%
1 Month
2.21%
3 Months
-4.15%
6 Months
-12.32%
1 Year
-37.07%
2 Year
-1.60%
Key data
Stock price
$1.85
P/E Ratio 
18.80
DAY RANGE
$1.81 - $1.89
EPS 
$0.11
52 WEEK RANGE
$1.60 - $3.14
52 WEEK CHANGE
-$31.73
MARKET CAP 
772.235 M
YIELD 
N/A
SHARES OUTSTANDING 
382.281 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-08-2025
BETA 
0.88
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,600,759
AVERAGE 30 VOLUME 
$1,666,591
Company detail
CEO: Michael R. Gorenstein
Region: US
Website: thecronosgroup.com
Employees: 450
IPO year: 2018
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for medical and adult-use markets.

Recent news
loading